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In 1999, Belgium faced a severe food crisis when about 50 kg of PCBs containing 1 g of dioxins 
were introduced in the food chain1. Great concerns were expressed about the public health impact 
of this food chain contamination. The possible increase of the dioxins body burden was first 
investigated through a Monte-Carlo simulation based on the dietary habits observed among 
adolescents and the PCBs/dioxins measurements in food carried out during the crisis2. The results 
of this study indicated that adverse health effects are unlikely to be observed owing to the low 
increase of the dioxins body burden caused by the crisis. In the meantime, an epidemiological 
survey was still in progress in order to validate the results of this simulation study. Indeed, unused 
frozen plasma collected in November-December 1998 were available from about 250 blood donors 
who agreed to provide a second blood sample in 2000-2001. In this way, 250 plasma samples 
collected before and after the crisis were available for analytical determinations. The aim of the 
present paper is to compare the results of the CALUX bioassay with those of the GC-HRMS 
analyses carried out in 209 of these plasma samples. 
 
Materials and Methods 
 
Blood Sampling 
Plasma samples were collected in polyethylene bags and directly frozen at – 80 °C after blood 
donation. Their volume ranged from 90 to 650 ml depending on the donation. In February 2002, 
they were defrost and divided into three aliquots: one for the analysis of 21 dioxin-like congeners 
(50-200ml), a second one for CALUX-TEQ analysis (20-60ml) and the last one for 7 PCBs 




The analyses of the 21 dioxin-like congeners (17 PCDD/Fs + 4 cPCBs) were performed by the 
CART. Details concerning the method have been previously described 3. Briefly, after addition of 
13C-labeled internal standards, 30-60ml of sample were mixed with formic acid and water (1:1:1). 
This mixture was loaded on a preconditioned Isolute C18 cartridge and target analytes were eluted 
with hexane. The extract was cleaned on a Power-Prep system with an automated multi-column 
clean-up using disposable silica, alumina and carbon. Purified extract with recovery standard were 
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then injected on a Helwett Packard 6890 serie Gas Chromatography- AUTOSPEC ULTIMA High 
Resolution Mass Spectrometer. TEQs of all congeners were calculated using 2,3,7,8-TCDD TEFs 
reported by WHO4.  
 
CALUX- analysis 
Bio-analyses were performed at the Scientific Institute of Public Health in Brussels. Briefly, 10ml 
of blood plasma was extracted with acetone and hexane and dried on a Celite/Na2SO4 column. The 
extract was then transferred on an Acid Silica column in series with an activated Carbon column 
(XCARB column). After elution of the sample with hexane, the acid silica column was discarded 
and the XCARB column was then differentially eluted to yield a PCB and a Dioxin fraction. This 
last fraction was evaporated and exposed to the mouse hepatoma H1L6.1 cell line developed by 
Xenobiotic Detection System, Inc. After an exposure time of 20h, cells were lysed and 
measurements were made with a luminometer 5. 
 
Lipid determination 
Because no data were available about the feeding state of donors before plasma donations, values 
were reported on a lipid weight basis 6. The lipid content of samples was enzymatically determined 
by the CART.  
 
Results and Discussion 
 
In this paper, only PCDD/Fs concentrations were taken into account for GC-HRMS TEQ values in 
order to compare those with results of the dioxin fraction in CALUX assay.  
 
Mean CALUX-analyses and mean GC-HRMS TEQ obtained from the 209 first analyses are quite 
similar to those observed in independent surveys carried out in Belgium (Table 1). However, some 
caution must be taken. Until now CALUX analyses in Belgium were performed using different 
purification protocols and different cell line. 
 
 Source CALUX analyses 
(pg TEQ/g fat) 
GC-HRMS analyses 
of PCDD/Fs 
(pg I-TEQ/g fat) 
Present study  (n=209) 40.5 (5.0 – 91.3) 25 (1.8 – 68.4)  
Nawrot & al, 2002 7  (n=200) 33.0 (2.0 – 243.5) - 
Pauwels & al, 2000 8  (n=106) 46.8 (2.0 – 160.2) - 
Fierens & al, 1999 9       Waste incinerators  (n=52) 
                      Controls  (n=27) 
- 
- 
36.7 (9.2 - 101.0)  
27.2 (5.0 – 71.0)  
Koppen & al, 2002 10  (n=47)                                   35.0 (4.2 – 64.9) 48.0 (31.2 – 81.3)  
 
Table 1: Mean TEQ-value (range) observed during various Belgian studies by CALUX  bioassay and GC-
HRMS 
 
A correlation coefficient of 0.71 has been found between the results of the CALUX bioassay and 
the results of the GC-HMRS determination (Figure 1). This correlation coefficient is quite 
comparable to those reported in previous publication12,13. However, the values measured by   
CALUX bioassay are significantly higher than concentrations of dioxins measured by chemical 
methods and this difference decreases as the concentration of dioxins gets higher. This bias 
between the two methods could be explained by various factors : 
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 1) Genetically modified cells used in bioassay are characterized by specific REP values which are 
different from WHO-TEFs 11. When multiplying concentrations of each congener measured by 
GC-HRMS with the corresponding REPs, TEQ-values very close to those calculated with WHO-
TEFs are obtained (difference from 0 to 2,5 pg TEQ/g fat). These new TEQ-values are presented 
on figure 1 by open cycles. These values should be considered as what we would measure by 
CALUX assay if only PCDD/Fs were present in the sample extract. Therefore, the obtained 
Bioassay results (open triangles) indicate the presence of additional compounds contributing to the 
TEQ-values in most samples. 
 
2) The potential of Bioassay to measure all compounds with AhR affinity, in addition with the 
observed non-additive effects of some molecules reacting with bio-analytical method14, could 
explain the biggest part of this discrepancy between the two methods. Environmental contaminants 
like brominated dioxins, PCT, PCN, etc … possibly go through the purification columns and take 
part in the CALUX response. More investigation is required to determine if these kinds of 
compounds finally reach the dioxin fraction, in which proportion and with which level of 
contribution to the bio-analysis TEQ-values.  
 
3) The last factor refers to the limit of quantification of GC-HRMS analyses. For samples with low 
levels of contamination, most of dioxin-like congeners are below the quantification limit. When 
the concentrations of these congeners are set to be zero, they do not contribute to the GC-HRMS 
TEQ-value. This could lead to an underestimation of the TEQ-value for chemical analyses at low 
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Figure 1: Comparison of CALUX 
analyses of the dioxin fraction and 
GC-HRMS analyses of the 17 
PCDD/Fs for human blood plasma. 
∆ :CALUX results (R:0,71), o : GC-
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Figure 2 : CALUX/GC-HRMS ratio as a 
function of concentrations measured by 
GC-HRMS 
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Figure 2 shows the importance of these three factors on the CALUX/GC-HRMS ratio at low 
concentrations. For values above 20 pg TEQ/g fat, the ratio ranges from 3 to 1. For lower level of 
contamination, the ratio varies from 9 to 5 if lower-bound values are taken in consideration. 
However, this last ratio is decreased to less than 3 when upper-bound values are used (data not 
shown). Similar trends were observed for samples of marine mammals analyzed by CALUX 




Because CALUX bioassay measures more dioxin-like compounds than the 17 specific PCDD/Fs 
congeners analyzed by chemical analysis it is not surprising that TEQ values obtained with bio-
analysis are higher than those reported with GC-HRMS. The bio-analytical method must be seen 
as a complementary method providing information about other environmental contaminations as 
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